Sinha Uma, officer (Chief Scientific Officer) of BBIO - Past Performance as of 06/01/20. Total 12 Records. Link to Thomson Financial
Buy(P) /
Sell(S)
P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
S 2019-12-18 2019-12-20 16:34:04.0 Eidos Therapeutics, Inc. EIDX Sinha Uma director officer (Chief Scientific Officer) 9,973 $61.61 $614,480.00 333,608 view
S 2019-12-18 2019-12-20 16:34:04.0 Eidos Therapeutics, Inc. EIDX Sinha Uma director officer (Chief Scientific Officer) 825 $62.49 $51,552.50 332,783 view
S 2019-12-18 2019-12-20 16:34:04.0 Eidos Therapeutics, Inc. EIDX Sinha Uma director officer (Chief Scientific Officer) 1,702 $63.31 $107,761.00 331,081 view
S 2019-09-25 2019-09-27 16:06:15.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 2,400 $38.38 $92,101.40 343,681 view
S 2019-09-25 2019-09-27 16:06:15.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 100 $39.15 $3,915.00 343,581 view
S 2019-07-25 2019-07-29 16:11:40.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 2,967 $35.65 $105,760.00 348,114 view
S 2019-07-25 2019-07-29 16:11:40.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 1,300 $36.53 $47,485.00 346,814 view
S 2019-07-25 2019-07-29 16:11:40.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 700 $37.31 $26,117.00 346,114 view
S 2019-07-25 2019-07-29 16:11:40.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 33 $38.35 $1,265.55 346,081 view
P 2019-07-01 2019-07-03 16:17:57.0 BridgeBio Pharma, Inc. BBIO Sinha Uma officer (Chief Scientific Officer) 14,000 $17.00 $238,000.00 14,000 view
S 2019-05-23 2019-05-28 16:02:41.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 4,200 $27.16 $114,072.00 350,112 view
S 2019-05-23 2019-05-28 16:02:41.0 Eidos Therapeutics, Inc. EIDX Sinha Uma officer (Chief Scientific Officer) 800 $27.88 $22,304.00 349,312 view
* Filed by insider as open market transaction, but marked as private transaction by insidercow's proprietary method